A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Clinical trial NCT06049667 · RECRUITING

Trial details

NCT number: NCT06049667
Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Start date: 2023-08-07
Primary completion: 2026-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.